Developments overseas have been totally ignored by the American press. And yet, since Election Day, the media have hewed to the “HCQ Bad” narrative.
Since most Americans who want to be vaccinated against COVID-19 will have to wait until spring—and cases are climbing—it is imperative that we focus on therapies to keep people out of the hospital and that we revisit the media-engineered saga of hydroxychloroquine.
Italy’s Council of State last week took a step in the right direction when it reversed the country’s July 22 ban on the off-label use of hydroxychloroquine. They issued this reversal following an appeal from a group of doctors seeking to use the anti-malarial drug for early outpatient treatment of COVID-19.
